Payment overview · 2025
General Payments
$61.06
2 reported records · 2 companies
Healthcare provider profile · identity verified
Festus N Arinze, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HUMBOLDT, TN · NPI 1114974086
Verified facts
What the public records show
CMS Open Payments records show Festus N Arinze, M.D. received $61.06 in general payments during 2025 across 2 reported records.
Lilly USA, LLC accounted for 73.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 402 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Trulicity by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $45.00 | 73.7% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $16.06 | 26.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $45.00 | 1 |
| Food and Beverage | $16.06 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $16.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
402 | 61 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1105 | 180 |
| Potassium Chloride | Potassium Chloride | 936 | 82 |
| Amlodipine Besylate | Amlodipine Besylate | 898 | 138 |
| Furosemide | Furosemide | 897 | 73 |
| Losartan Potassium | Losartan Potassium | 756 | 76 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 741 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 721 | 99 |
| Levothyroxine Sodium | Levothyroxine Sodium | 628 | 60 |
| Lisinopril | Lisinopril | 603 | 102 |
| Gabapentin | Gabapentin | 572 | 86 |
| Trazodone Hcl | Trazodone Hcl | 567 | 50 |
| Metformin Hcl | Metformin Hcl | 564 | 102 |
| Omeprazole | Omeprazole | 538 | 70 |
| Hydralazine Hcl | Hydralazine Hcl | 500 | 45 |
| Famotidine | Famotidine | 489 | 78 |
| Metoprolol Tartrate | Metoprolol Tartrate | 469 | 67 |
| Eliquis | Apixaban | 406 | 30 |
| Jardiance | Empagliflozin | 402 | 61 |
| Buspirone Hcl | Buspirone Hcl | 387 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 336 | 48 |
| Lamotrigine | Lamotrigine | 335 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 319 | 68 |
| Carvedilol | Carvedilol | 313 | 41 |
| Simvastatin | Simvastatin | 313 | 18 |
| Donepezil Hcl | Donepezil Hcl | 310 | 22 |
| Meloxicam | Meloxicam | 310 | 70 |
| Sertraline Hcl | Sertraline Hcl | 308 | 23 |
| Mirtazapine | Mirtazapine | 307 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 300 | 17 |
| Rivastigmine | Rivastigmine | 281 | 12 |
| Levetiracetam | Levetiracetam | 279 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 272 | 72 |
| Duloxetine Hcl | Duloxetine Hcl | 268 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 268 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 257 | 43 |
| Fluoxetine Hcl | Fluoxetine Hcl | 221 | 18 |
| Allopurinol | Allopurinol | 219 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 215 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 209 | 49 |
| Labetalol Hcl | Labetalol Hcl | 194 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 188 | 74 |
| Ozempic | Semaglutide | 180 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 162 | 31 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 154 | 16 |
| Spironolactone | Spironolactone | 150 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 148 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 145 | 28 |
| Divalproex Sodium | Divalproex Sodium | 143 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 142 | suppressed |
| Carbamazepine | Carbamazepine | 130 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 129 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 129 | 34 |
| Baclofen | Baclofen | 126 | 13 |
| Montelukast Sodium | Montelukast Sodium | 124 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 123 | 14 |
| Verapamil Er | Verapamil Hcl | 120 | suppressed |
| Alprazolam | Alprazolam | 115 | 20 |
| Lansoprazole | Lansoprazole | 111 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 111 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 110 | 79 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 110 | 19 |
| Olanzapine | Olanzapine | 110 | suppressed |
| Lorazepam | Lorazepam | 108 | 15 |
| Farxiga | Dapagliflozin Propanediol | 106 | 14 |
| Pregabalin | Pregabalin | 104 | 12 |
| Prednisone | Prednisone | 102 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 102 | 13 |
| Memantine Hcl | Memantine Hcl | 101 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 101 | 19 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 99 | suppressed |
| Januvia | Sitagliptin Phosphate | 97 | suppressed |
| Glimepiride | Glimepiride | 96 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 95 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 91 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 90 | suppressed |
| Finasteride | Finasteride | 86 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 83 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 81 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 25 |
| Alendronate Sodium | Alendronate Sodium | 76 | 13 |
| Ezetimibe | Ezetimibe | 75 | 23 |
| Sucralfate | Sucralfate | 73 | 11 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 71 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | suppressed |
| Linzess | Linaclotide | 69 | 20 |
| Risperidone | Risperidone | 69 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 43 |
| Ramipril | Ramipril | 67 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 19 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 65 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 65 | suppressed |
| Calcitriol | Calcitriol | 64 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 64 | suppressed |
| Lovastatin | Lovastatin | 63 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 62 | 12 |
| Topiramate | Topiramate | 62 | suppressed |
| Methylprednisolone | Methylprednisolone | 61 | 45 |
| Lacosamide | Lacosamide | 60 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 59 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 59 | 11 |
| Hydrocortisone | Hydrocortisone | 59 | suppressed |
| Anastrozole | Anastrozole | 57 | suppressed |
| Clonazepam | Clonazepam | 57 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 57 | suppressed |
| Atenolol | Atenolol | 55 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 55 | suppressed |
| Ketoconazole | Ketoconazole | 54 | suppressed |
| Amantadine | Amantadine Hcl | 53 | suppressed |
| Bicalutamide | Bicalutamide | 53 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 41 |
| Metformin Hcl Er | Metformin Hcl | 53 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 53 | suppressed |
| Nystatin | Nystatin | 51 | 18 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 51 | suppressed |
| Fluconazole | Fluconazole | 49 | 27 |
| Myrbetriq | Mirabegron | 49 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 48 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 45 | suppressed |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | suppressed |
| Methocarbamol | Methocarbamol | 44 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 44 | suppressed |
| Primidone | Primidone | 43 | suppressed |
| Phenytoin | Phenytoin | 42 | suppressed |
| Torsemide | Torsemide | 42 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 40 | suppressed |
| Colchicine | Colchicine | 39 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | suppressed |
| Nystop | Nystatin | 39 | 13 |
| Nitroglycerin | Nitroglycerin | 38 | 24 |
| Propranolol Hcl | Propranolol Hcl | 38 | suppressed |
| Temazepam | Temazepam | 38 | suppressed |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 37 | suppressed |
| Modafinil | Modafinil | 37 | suppressed |
| Levemir | Insulin Detemir | 35 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 35 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Azithromycin | Azithromycin | 33 | 23 |
| Cilostazol | Cilostazol | 33 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 33 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Novolin R | Insulin Regular, Human | 33 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Scopolamine | Scopolamine | 32 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 31 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 31 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 31 | suppressed |
| Calcium Acetate | Calcium Acetate | 30 | suppressed |
| Diazepam | Diazepam | 30 | suppressed |
| Levofloxacin | Levofloxacin | 30 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Crestor | Rosuvastatin Calcium | 28 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 23 |
| Ceftriaxone | Ceftriaxone Sodium | 26 | 16 |
| Phenobarbital | Phenobarbital | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Amoxicillin | Amoxicillin | 23 | 18 |
| Lidocaine | Lidocaine | 23 | suppressed |
| Nabumetone | Nabumetone | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Haloperidol | Haloperidol | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Zonisamide | Zonisamide | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Nyamyc | Nystatin | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 16 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 15 | suppressed |
| Xifaxan | Rifaximin | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 14 |
| Lactulose | Lactulose | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Metoprolol-Hydrochlorothiazide | Metoprolol/Hydrochlorothiazide | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 11 | suppressed |
| Vardenafil Hcl | Vardenafil Hcl | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $61.06 · 2 records | Lilly USA, LLC | REXULTI | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error